Jeena Sikho Lifecare Ltd

Acquisition details

• Target: Jeena Sikho Lifecare Limited.
• Disclosing party: Bhavna Grover (Promoter).
• Transaction type: Acquisition of equity shares through open market purchase.
• Pre-transaction holding: 2,78,000 shares (0.22%), encumbrance Nil.
• Acquired: 25,000 shares (0.02%) via open market purchase.
• Post-transaction holding: 3,03,000 shares (0.24%).
• Date of acquisition: 29 September 2026.
• Capital context: Rs 24,86,01,460; 12,43,00,730 equity shares (Rs 2 each).

Promoter open market purchase

• Promoter Bhavna Grover bought 25,000 equity shares on 29 September 2026.
• Pre-acquisition holding: 2,78,000 shares (0.22%); after: 3,03,000 shares (0.24%).
• Promoter group holding rose from 63.62% to 63.66%.
• Equity capital remains Rs 24,86,01,460 across 12,43,00,730 shares.
• Mode of acquisition: open market purchase.

Promoter open market acquisition

• Promoter Bhavna Grover purchased 25,000 Jeena Sikho Lifecare shares on 29 September 2026.
• Pre-holding: 2,78,000 shares (0.22%); post-holding: 3,03,000 shares (0.24%).
• Aggregate promoter group holding rose from 63.62% to 63.66% after the transaction.
• Acquirer is promoter; PAC not applicable.
• Equity share capital unchanged at Rs 24,86,01,460 (12,43,00,730 shares).
• Listing on NSE and BSE; acquisition date 29 Sep 2026; mode: open market.
• Total diluted share capital after acquisition: 12,43,00,730 shares.

Promoter acquisition under Reg 29(2)

• Promoter Bhavna Grover purchased 35,000 Jeena Sikho Lifecare shares via open market on 28 September 2026.
• Pre-transaction promoter holding was 2,43,000 shares (0.20%).
• Post-transaction holding rises to 2,78,000 shares (0.22%).
• Aggregate promoter group shareholding in target increased from 63.62% to 63.64%.
• Total voting capital remains 12,43,00,730 shares; promoter stake now 0.22%.
• Acquisition method: open market purchase; date of acquisition: 28 September 2026.

Key details

• Target Company: Jeena Sikho Lifecare Limited.
• Disclosing Party: Bhavna Grover, Promoter; PAC not applicable.
• Transaction Type: Acquisition of equity shares via open market.
• Pre-Transaction Holding: 2,43,000 shares (0.20%).
• Acquired 35,000 shares (0.02%) via open market.
• Post-Transaction Holding: 2,78,000 shares (0.22%).
• Date of transaction: 28 September 2026.
• Share capital context: Share capital before/after Rs 24,86,01,460; 12,43,00,730 shares; diluted capital same.

Promoter share acquisition

• Promoter Bhavna Grover purchased 35,000 shares via open market on 28 Sep 2026.
• Pre-holding: 243,000 shares (0.20%); post-holding: 278,000 shares (0.22%).
• Promoter group stake rose from 63.62% to 63.64% post-transaction.
• Open market purchase dated 28 September 2026.
• Total equity share capital remains Rs 24.86 crore across 12,430,073 shares.

AGM Details & Resolutions

• AGM held on 28 September 2026 at 12:00 Noon in Zirakpur, Punjab (physical meeting).
• To adopt standalone financial statements for FY ended 31 March 2026.
• To adopt consolidated financial statements for FY ended 31 March 2026.
• To declare final dividend of ₹4.50 per equity share.
• To reappoint Mrs. Bhavna Grover as Director on rotation.
• To reappoint Mr. Karan Vir Bindra as Independent Director.
• To reappoint Mrs. Bhavna Grover as Whole-time Director and KMP.
• To reappoint Mr. Manish Grover as Managing Director and KMP.
• To appoint Mr. Ajay Sharma as Non-Executive Independent Director.
• To appoint Mrs. Sapna Singh as Non-Executive Woman Independent Director.
• To appoint Dr Ish Sharma as Director.
• To appoint Dr Ish Sharma as Whole-Time Director and KMP.
• To appoint Mr. Ankush Kaushal as Director.
• To appoint Mr. Ankush Kaushal as Whole-Time Director and KMP.
• To seek member approval for loans/guarantees/securities under Section 185.
• To seek member approval for loans/guarantees/investments under Section 186.
• Voting results to be announced within two working days from conclusion.

Jeena Sikho Lifecare Limited — Trading Window closed from 1 October 2026 till 48 hours after the declaration of the Unaudited Financial Results for the quarter and half year ended 30 September 2026.